Streetbeat News

Earnings

ORCL

Oracle is set to release its earnings report, with expectations of a profit of $1.48 per share on sales of $14.1 billion.

Portfolio Pulse from

December 09, 2024 | 9:00 pm

ACRE

Ares Commercial Real Estate has been downgraded from 'Buy' to 'Hold' due to its failure to cover dividends with distributable profits in 3Q24, high dividend adjustment risk, and ongoing loan issues. The company's portfolio has shrunk by 15%, leading to a significant drop in profits and negative net income.

Portfolio Pulse from

December 09, 2024 | 8:45 pm

COST

Costco Wholesale (COST) is expected to report rising revenue and profits for Q1 fiscal 2025. Analysts suggest the possibility of a stock split due to the company's robust performance.

Portfolio Pulse from

December 09, 2024 | 8:15 pm

MRVL

Marvell (MRVL) reported impressive Q3 earnings, driven by significant growth in AI-related sales. The company's data center revenue increased by 98% year-over-year, highlighting its successful entry into the AI market.

Portfolio Pulse from

December 09, 2024 | 7:30 pm

AAPL

Apple's Q4 earnings report received mixed reviews from analysts, but the focus should be on its strong installed base, growing service revenues, and margin expansion potential. Its valuation is attractive due to high return on capital and a capital-light model.

Portfolio Pulse from

December 09, 2024 | 7:15 pm

ADRNY

Ahold Delhaize has seen a 37% increase in value, including FX and dividends, despite 0% EPS growth in 2023 and expected 0% in 2024. The stock returned to its standard valuation, indicating market recognition of its true value.

Portfolio Pulse from

December 09, 2024 | 7:00 pm

BCRX

BioCryst Pharmaceuticals is recommended as a 'Buy' due to the success and growth potential of its drug ORLADEYO, despite competition and a one-dimensional revenue stream. Q3 2024 results showed a modest revenue beat but a slight earnings miss, causing a 13% stock drop. ORLADEYO's revenue is expected to reach $1 billion annually by 2029.

Portfolio Pulse from

December 09, 2024 | 7:00 pm

EXEL

Exelixis (EXEL) is highlighted as a strong growth stock with potential to outperform the market due to its above-average financial growth.

Portfolio Pulse from

December 09, 2024 | 7:00 pm

PEN

Penumbra (PEN) is highlighted as a strong growth stock with potential to outperform the market due to its above-average financial growth.

Portfolio Pulse from

December 09, 2024 | 7:00 pm

GDS

GDS Holdings (GDS) has been upgraded to a Zacks Rank #2 (Buy) due to growing optimism about its earnings prospects. This upgrade suggests potential positive movement in GDS's stock price.

Portfolio Pulse from

December 09, 2024 | 6:30 pm